Duke University Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $515,990,255
Contract Count: 23
Average Contract Size: $22.4M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- Other: $516.0M (23 contracts)
Contracts
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE — $78.2M
- THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST — $66.5M
- TAS::75 0140::TAS — $49.0M
- IGF::OT::IGF EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) — $37.3M
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) — $35.8M
- TAS::75 0885::TASEXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY — $32.8M
- NATIONAL CORD BLOOD INVENTORY — $26.5M
- DATA AND STATISTICS CENTER FOR THE CLINICAL TRIALS NETWORK — $24.3M
- IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA) — $24.2M
- TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLOOD INVENTORY — $19.1M
- TAS::75 0885::TAS TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE — $18.4M
- "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES" — $18.2M
- Contract — $13.2M
- IGF::OT::IGF1300017I DUKE UNIVERSITY; TASK ORDER HHSN27200008-14-0053.A1B1C1D1.0026- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL IN ADULTS WITH COMMUNITY ACQUIRED PNEUMONIA; BASE $141,485, OPTION 1 $67,837, OPTION 2 $4,049,893, AND OPTION 4 $798,412 — $12.0M
- MGT SVCS/CONTRACT&PROCUREMENT SUP — $11.7M
- Contract — $11.6M
- BIOMEDICAL (APPLIED/EXPLORATORY) — $11.4M
- BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS — $8.8M
- FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA — $5.9M
- NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT — $5.1M
Frequently Asked Questions
How many contracts does Duke University have with Department of Health and Human Services?
Duke University has 23 contracts with Department of Health and Human Services worth a combined $516.0M.
What is the average contract size between Duke University and Department of Health and Human Services?
The average contract size is $22.4M.
What percentage of Duke University's contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.